Jung Hyun Kwon
Overview
Explore the profile of Jung Hyun Kwon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
1238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lee J, Jin Y, Shin S, Kwon J, Kim S, Yu J, et al.
J Gastroenterol Hepatol
. 2024 May;
39(9):1924-1931.
PMID: 38711168
Background And Aim: Transarterial chemoembolization (TACE) is one of the standard modalities used to treat unresectable hepatocellular carcinoma (HCC), but the effectiveness of TACE for treating patients with a solitary...
12.
Nam H, Han J, Lee S, Yang H, Lee H, Sung P, et al.
J Gastroenterol Hepatol
. 2024 May;
39(8):1673-1683.
PMID: 38690711
Background And Aim: Our study evaluated the outcomes of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in patients with chronic hepatitis B (CHB). We assessed viral and...
13.
Han J, Sung P, Yoo J, Cho H, Lee S, Yang H, et al.
Front Oncol
. 2024 Mar;
14:1372007.
PMID: 38482199
Background: Atezolizumab+bevacizumab (AB) and lenvatinib have been proposed as first-line treatment options for patients with advanced hepatocellular carcinoma (HCC), but comparative efficacy and associated factors are controversial. Materials And Methods:...
14.
Lee S, Nam S, Jang J, Kwon J
Diagnostics (Basel)
. 2024 Mar;
14(5).
PMID: 38472967
The long-term kinetics of quantitative HBsAg levels in HBV-infected patients treated with entecavir or tenofovir, as well as the role of quantitative HBsAg in predicting functional cure (HBsAg loss) and...
15.
Kim J, Kim S, Song D, Kim H, Yoon E, Kang S, et al.
Diagnostics (Basel)
. 2024 Jan;
14(1).
PMID: 38201324
Background: The European Foundation for the Study of Chronic Liver Failure (EF-CLIF) consortium suggested that the clinical courses after acute decompensation (AD) stratify the long-term prognosis: stable decompensated cirrhosis (SDC),...
16.
Lee S, Kwon J, Lee S, Lee H, Kim H, Kim C, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686699
This study aimed to compare the treatment outcomes of atezolizumab-plus-bevacizumab (Ate/Bev) therapy with those of transarterial chemoembolization plus radiotherapy (TACE + RT) in hepatocellular carcinoma (HCC) patients with portal vein...
17.
Kang J, Jun J, Kwon J, Lee J, Hwang K, Kim S, et al.
Genes (Basel)
. 2023 Jul;
14(7).
PMID: 37510380
Although a large number of databases are available for regulatory elements, a bottleneck has been created by the lack of bioinformatics tools to predict the interaction modes of regulatory elements....
18.
Heo J, Kim Y, Lee S, Lee Y, Yoon K, Byun K, et al.
Korean J Intern Med
. 2023 Jul;
38(4):504-513.
PMID: 37424500
Background/aims: Despite the availability of direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection in Korea, need remains for pangenotypic regimens that can be used in the presence of...
19.
Yoo S, Kim S, Kim S, Kwon J, Lee H, Seo Y, et al.
J Liver Cancer
. 2023 Jun;
23(1):189-201.
PMID: 37384020
Background/aim: Abdominal ultrasonography (USG) is recommended as a surveillance test for high-risk groups for hepatocellular carcinoma (HCC). This study aimed to analyze the current status of the national cancer surveillance...
20.
Kim J, Cheng J, Nam T, Kim J, Jang B, Huang W, et al.
Cancers (Basel)
. 2023 Jun;
15(12).
PMID: 37370774
Purpose: Although systemic treatment is the mainstay for advanced hepatocellular carcinoma (HCC), numerous studies have highlighted the added value of local treatment. This study aimed to investigate the clinical efficacy...